Inventia Life Science collaborates with MSD to develop 3D advanced cell models for neurodegenerative disease drug discovery
Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTRUM SYDNEY, Feb. 16, 2023 /PRNewswire/ -- February 16, 2023, Inventia Life Science, a world leader in advanced cell models for biomedical research and drug discovery, today announced a collaboration with MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA) using Inventia's RASTRUM 3D cell culture platform. Through this collaboration, novel bioprinting capabilities offered by RASTRUM will be utilised to create 3D in vitro models...
Source: singaporestar.com